RYCPX
Price
$65.32
Change
+$1.14 (+1.78%)
Updated
Jul 2 closing price
Net Assets
31.03M
VCSAX
Price
$113.71
Change
+$2.37 (+2.13%)
Updated
Jul 2 closing price
Net Assets
9.1B
Interact to see
Advertisement

RYCPX vs VCSAX

RYCPX vs VCSAX Comparison Chart in %
View a ticker or compare two or three
VS
RYCPX vs. VCSAX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCPX is a Buy and VCSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCSAX has more cash in the bank: 9.1B vs. RYCPX (31M). RYCPX pays higher dividends than VCSAX: RYCPX (2.55) vs VCSAX (2.13). RYCPX was incepted earlier than VCSAX: RYCPX (25 years) vs VCSAX (22 years). RYCPX (2.43) is less costly to investors than VCSAX (0.09). RYCPX is a more actively managed with annual turnover of: 57.00 vs. VCSAX (9.00). RYCPX has a lower initial minimum investment than VCSAX: RYCPX (2500) vs VCSAX (100000). VCSAX annual gain was more profitable for investors over the last year : 3.95 vs. RYCPX (-23.64). VCSAX return over 5 years is better than : 27.27 vs. RYCPX (-53.84).
RYCPXVCSAXRYCPX / VCSAX
Total Expense Ratio2.380.092,644%
Annual Report Gross Expense Ratio2.430.092,700%
Fund Existence25 years22 years-
Gain YTD9.5249.221103%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRA1000N/A-
Net Assets31M9.1B0%
Annual Yield % from dividends2.552.13120%
Returns for 1 year-23.643.95-599%
Returns for 3 years-39.1818.41-213%
Returns for 5 years-53.8427.27-197%
Returns for 10 years-57.6464.75-89%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLLX17.840.26
+1.48%
MFS Global Real Estate R3
TOLZX16.320.23
+1.43%
DWS RREEF Global Infrastructure R6
TSFYX17.170.13
+0.76%
Touchstone Small Cap Y
MIGHX39.670.24
+0.61%
MFS Massachusetts Inv Gr Stk R3
RYCKX45.15-0.66
-1.44%
Rydex S&P MidCap 400 Pure Growth C